Comparative studies on the effects of doxorubicin and differentiation inducing agents on B16 melanoma cells
- 31 May 1992
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 28 (4-5), 778-783
- https://doi.org/10.1016/0959-8049(92)90114-h
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Different susceptibilities of melanoma cells to retinoic acid-induced changes in melanotic expressionBiochemical and Biophysical Research Communications, 1988
- Cyclic amp induces differentiation in vitro of human melanoma cellsCancer, 1988
- Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme‐linked immunoadsorbent assay and by immunotitration analysisJournal of Cellular Physiology, 1988
- Differentiation apparently repressed by the nucleusExperimental Cell Research, 1987
- Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxideExperimental Cell Research, 1986
- Regulation of tyrosinase in human melanocytes grown in culture.The Journal of cell biology, 1983
- Control of melanin synthesis and secretion by B16/C3 melanoma cellsJournal of Cellular Physiology, 1982
- Tyrosinase maturation and pigment expression in B16 melanoma: Relation to theophylline treatment and intracellular cyclic AMPJournal of Cellular Physiology, 1979
- Factors Regulating Growth And Pigmentation Of Melanoma CellsJournal of Investigative Dermatology, 1976
- Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cellsNature, 1975